Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows

v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities:    
Net loss $ (81,555) $ (1,055,265)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 74,166 80,425
Impairment of goodwill 0 1,092,714
Share-based compensation expense 7,669 5,187
Provision for revenue adjustments 1,637 2,159
Deferred income tax benefit (4,725) (163,604)
Other 14,472 6,469
Changes in operating assets and liabilities, net of effects from the purchase of acquired businesses:    
Accounts receivable (16,945) (42,265)
Other receivables 309 5,531
Other current and noncurrent assets 9,719 (56,637)
Accounts payable and accrued expenses 9,651 28,362
Net cash provided by (used in) operating activities of continuing operations 14,398 (96,924)
Investing activities:    
Proceeds from sale of property and equipment 1,495 1,406
Purchases of property and equipment (16,650) (19,396)
Purchase of a business, net of cash acquired 0 (1,565,242)
Other 31 (174)
Net cash used in investing activities of continuing operations (15,124) (1,583,406)
Financing activities:    
Repayments of finance lease obligations (9,376) (9,127)
Proceeds from credit facility 85,000 0
Payments on credit facility (85,000) (80,000)
Payment of debt issuance costs 0 (60,591)
Payment of earn-out liability 0 (12,247)
Proceeds from common stock issued under employee stock purchase plan 434 369
Payment of minimum tax withholdings on share-based awards (1,001) (1,361)
Net cash used in financing activities of continuing operations (9,943) (162,957)
Effect of exchange rate changes on cash 710 745
Net decrease in cash and cash equivalents and restricted cash and restricted cash equivalents from continuing operations (9,959) (1,842,542)
Cash from discontinued operation:    
Net cash used in operating activities of discontinued operations 0 (4,876)
Net decrease in cash and cash equivalents, and restricted cash and restricted cash equivalents (9,959) (1,847,418)
Cash and cash equivalents, and restricted cash and restricted cash equivalents at beginning of period 105,266 1,952,073
Cash and cash equivalents, and restricted cash and restricted cash equivalents at end of period 95,307 104,655
Reconciliation of cash and cash equivalents, and restricted cash and restricted cash equivalents    
Cash and cash equivalents 95,128 84,886
Restricted cash and restricted cash equivalents 179 19,769
Total cash and cash equivalents, and restricted cash and restricted cash equivalents shown in the condensed consolidated statement of cash flows: $ 95,307 $ 104,655